Insights
Why Home Healthcare and Hospice is Getting Investor Attention
January 17, 2022
Investors are currently seeking opportunities that will allow them to invest their funds in safe-havens.
Prior to the pandemic, the market saw investors being more active in the home healthcare and hospice industry. Private equity investment within the space was at an all-time high in 2019. Private equity has been interested in the space because the industry has favorable reimbursement policies in the United States, and patients are becoming less reliant on visiting hospitals.
The pandemic has allowed for remote monitoring and has made virtual visits more mainstream. This new level of normalcy has opened more opportunities within the sector. If an investor is seeking to diversify their traditional practices, many investors feel that home health businesses are ideal to integrate with traditional providers. The attractiveness of the sector has trade, synergistic, and new investors seeking opportunities within space.
You may ask what is driving the interest in this market. According to the U.S. Census Bureau, by 2030, approximately 12% of the world population will be 65 or older. Baby Boomers that currently own many companies within the space are also aging and looking to retire. The pandemic has also accelerated some business owners’ exit strategies, which has allowed more quality businesses to be available for sale.
Grata, a private company intelligence engine, estimates that there are 305 home healthcare companies in North America. Of these 305 home healthcare companies, it is estimated that 90% remain independently owned. Florida, California, and New York—in that order—have the highest concentration of home healthcare companies, and around 50% of the companies within the space have 51-5,000 employees. With only roughly 7% of the sector receiving funding to date, there are still plenty of opportunities for investment and consolidation within the space.
Whether you are a first-time acquirer or a seasoned professional, if you haven’t considered home healthcare acquisitions in the past, 2022 might be the year to reconsider your search parameters.
Author
Kendall Stafford
Managing Partner
Benchmark International
Share This Post
Categories
Get These Insights Delivered Directly To Your Email
Explore our curated collection today and stay ahead of the curve in M&A.
Related Posts
Why Negotiating the Tough Stuff Upfront in a Letter of Intent is Crucial in M&A TransactionsWhen you're selling your business, the most challenging negotiations are the ones that often get pushed aside, but they are the ones that should be tackled upfront. The ESOP Advantage in M&A: What Buyers and Sellers Need to KnowESOPs have a special place in the business world. There's a bit of mystery around them as they are outside of typical business structures, and many need to understand how they work, much less their role in an M&A transaction. Some ESOPs seeking to sell are curious if they can do so with an ESOP in place. Others looking to buy or be bought out by an ESOP aren't sure of the proceedings. Fortunately, Benchmark has managed both situations and can navigate deals with these added layers of complexity.